Alkermes
ALKS
#2942
Rank
โ‚ฌ4.72 B
Marketcap
28,59ย โ‚ฌ
Share price
-2.84%
Change (1 day)
-7.08%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): โ‚ฌ0.36 Billion

According to Alkermes's latest financial reports the company's current earnings are โ‚ฌ1.52 Billion. In 2024 the company made an earning of โ‚ฌ0.39 Billion a decrease over its 2023 earnings that were of โ‚ฌ0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.36 B-6.95%
2024 โ‚ฌ0.39 B-17.97%
2023 โ‚ฌ0.47 B-468.52%
2022 -โ‚ฌ0.14 Billion449.24%
2021 -โ‚ฌ23.7 Million-68.04%
2020 -โ‚ฌ74.14 Million-52.1%
2019 -โ‚ฌ0.16 Billion64.49%
2018 -โ‚ฌ94.09 Million-15.04%
2017 -โ‚ฌ0.12 Billion-34.2%
2016 -โ‚ฌ0.17 Billion-5.34%
2015 -โ‚ฌ0.18 Billion35084.97%
2014 -โ‚ฌ0.51 Million
2012 โ‚ฌ6.26 M-117.81%
2011 -โ‚ฌ35.17 Million-12.69%
2010 -โ‚ฌ40.28 Million94.3%
2009 -โ‚ฌ20.73 Million-117.7%
2008 โ‚ฌ0.11 B622.63%
2007 โ‚ฌ16.2 M
2004 -โ‚ฌ64.09 Million-14.48%
2003 -โ‚ฌ74.95 Million11.88%
2002 -โ‚ฌ66.99 Million39.65%
2001 -โ‚ฌ47.97 Million5.73%
2000 -โ‚ฌ45.37 Million-28.91%
1999 -โ‚ฌ63.82 Million237.28%
1998 -โ‚ฌ18.92 Million100.05%
1997 -โ‚ฌ9.46 Million-37.93%
1996 -โ‚ฌ15.24 Million82.72%
1995 -โ‚ฌ8.34 Million-26.79%
1994 -โ‚ฌ11.39 Million-72.78%
1993 -โ‚ฌ41.85 Million208.07%
1992 -โ‚ฌ13.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.32 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.85 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.99 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.67 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ6.77 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.04 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-โ‚ฌ0.18 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.23 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.49 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel